These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 5509491)

  • 21. Tardive dyskinesia in schizophrenic patients treated with psychotropic drugs.
    Crane GE
    Agressologie; 1968; 9(2):209-18. PubMed ID: 5675488
    [No Abstract]   [Full Text] [Related]  

  • 22. [Side effects of neuroleptics in compound preparations].
    Schulte PW; Zimmermann H
    Med Klin; 1971 Nov; 66(48):1644-8. PubMed ID: 4400005
    [No Abstract]   [Full Text] [Related]  

  • 23. [Late extrapyramidal hyperkineses after prolonged neuroleptic therapy].
    Hippius H; Lange J
    Arzneimittelforschung; 1970 Jul; 20(7):888-90. PubMed ID: 5536050
    [No Abstract]   [Full Text] [Related]  

  • 24. Relationship of individual tolerance, behavior and phenothiazine produced extrapyramidal system disturbance.
    Simpson GM; Kunz-Bartholini E
    Dis Nerv Syst; 1968 Apr; 29(4):269-74. PubMed ID: 5652493
    [No Abstract]   [Full Text] [Related]  

  • 25. [Persistent extrapyramidal oral dyskinesia following administration of thymoleptics].
    Sedivec V; Valenová Z; Paceltová L
    Cesk Psychiatr; 1969 Aug; 65(4):241-4. PubMed ID: 5807247
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long-acting injectable neuroleptic, in chronic psychotic patients.
    Tanghe A; Vereecken JL
    Psychiatr Neurol Neurochir; 1971; 74(5):379-89. PubMed ID: 5138128
    [No Abstract]   [Full Text] [Related]  

  • 27. [Nil nocere. Dyskinetico-hypertensive side effects following Tonoquil].
    Hansen HW; van Zwieten PA
    Munch Med Wochenschr; 1969 Jan; 111(5):241-4. PubMed ID: 5819129
    [No Abstract]   [Full Text] [Related]  

  • 28. [The semiology of motor function disorders during treatment with neuroleptic drugs].
    Fleĭs EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(12):1798-804. PubMed ID: 5511943
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug-induced extrapyramidal disorders.
    Chase TN
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():448-71. PubMed ID: 4341954
    [No Abstract]   [Full Text] [Related]  

  • 30. [Paroxysmal extrapyramidal syndrome caused by taking neuroleptic drugs].
    Gurovich IIa; Fleĭs EP
    Klin Med (Mosk); 1969 Sep; 47(9):132-7. PubMed ID: 5397873
    [No Abstract]   [Full Text] [Related]  

  • 31. [Side effects of psychopharmacologic agents simulating neurologic disease symptoms].
    Möllhoff G
    Lebensversicher Med; 1969 Jul; 21(4):85-9. PubMed ID: 4389764
    [No Abstract]   [Full Text] [Related]  

  • 32. Extrapyramidal side effects of psychotropic drugs.
    Greenblatt DJ; Shader RI; DiMascio A
    Conn Med; 1969 Mar; 33(3):197-201. PubMed ID: 5773504
    [No Abstract]   [Full Text] [Related]  

  • 33. [Movement disorders as a concomitant syndrome in the use of psychopharmacological agents].
    von der Mühlen H
    Z Allgemeinmed; 1973 Oct; 49(30):1441-7. PubMed ID: 4768492
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug-induced extrapyramidal symptoms: their incidence and treatment.
    Sheppard C; Merlis S
    Am J Psychiatry; 1967 Jan; 123(7):886-9. PubMed ID: 6016862
    [No Abstract]   [Full Text] [Related]  

  • 35. Side-effects of phenothiazines.
    Lowther J
    Br J Psychiatry; 1967 May; 113(498):557-8. PubMed ID: 6033501
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
    Kamianov IM; Kupisk AG; Katsen IZ
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(8):1218-23. PubMed ID: 4149581
    [No Abstract]   [Full Text] [Related]  

  • 37. Perphenazine-benztropine mesylate treatment of newly admitted psychiatric patients.
    Hanlon TE; Schoenrich C; Freinek W; Turek I; Kurland AA
    Psychopharmacologia; 1966; 9(4):328-39. PubMed ID: 4874349
    [No Abstract]   [Full Text] [Related]  

  • 38. The prevalence of tardive dyskinesias in mental hospital patients.
    Fann WE; Davis JM; Janowsky DS
    Dis Nerv Syst; 1972 Mar; 33(3):182-6. PubMed ID: 5022453
    [No Abstract]   [Full Text] [Related]  

  • 39. [Extrapyramidal symptoms during the use of neuroleptics].
    Ditfurth HV
    Nervenarzt; 1967 Apr; 38(4):151-5. PubMed ID: 4382350
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neuroleptic dyskinetic reactions and schizophrenia].
    Eckmann F; Immich H
    Nervenarzt; 1965 Aug; 36(8):358-9. PubMed ID: 5862721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.